Pacheco Claudio Christine, Charbonney Emmanuel, Durand Madeleine, Kolan Christophe, Laskine Mikhael
Centre Hospitalier de l'Universite de Montreal, Montreal, Canada.
Hopital de Trois-Rivieres and Hopital du Sacre-Coeur de Montreal, Montreal, Canada.
J Clin Med Res. 2014 Apr;6(2):145-8. doi: 10.14740/jocmr1685w. Epub 2014 Feb 6.
Diffuse alveolar hemorrhage (DAH) is a rare and potentially deadly complication of systemic lupus erythematosus (SLE). We report two adult cases where extracorporeal membrane oxygenation (ECMO) was used as rescue therapy for severe respiratory failure in this setting. We discuss the risk related to coagulation disturbance and the need for the circuit anticoagulation in this particular setting. We also briefly discuss the clinical problem of lack of knowledge on the bioavailability of the immunosuppressive treatment with the use of ECMO. We think that ECMO should be used as rescue therapy in patients with DAH caused by SLE, but strategies for anticoagulation require further precision.
弥漫性肺泡出血(DAH)是系统性红斑狼疮(SLE)一种罕见且可能致命的并发症。我们报告了两例成年患者,在此情况下使用体外膜肺氧合(ECMO)作为严重呼吸衰竭的抢救治疗方法。我们讨论了与凝血障碍相关的风险以及在此特殊情况下回路抗凝的必要性。我们还简要讨论了在使用ECMO时,对于免疫抑制治疗生物利用度缺乏了解这一临床问题。我们认为,ECMO应用于SLE所致DAH患者的抢救治疗,但抗凝策略需要进一步精准化。